Orphan drugs face “uphill battle” in 2020 by Anna Smith | Mar 5, 2020 | News | 0 EMA-assigned Orphan Drug Designations declined 49% between 2014 and 2019. Read More
Biogen pays $120 million for late-stage stroke treatment Cirara by Dominic Tyer | May 17, 2017 | News | 0 Strikes licensing deal with Remedy Pharmaceuticals Read More
FDA to fast-track Pfizer/Sangamo gene therapy orphan drug by Dominic Tyer | May 17, 2017 | News | 0 SB-525 is being developed to treat haemophilia A Read More